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Abstract
Overexpression of Smad ubiquitin regulatory factor 2 (Smurf2) in chondrocytes was
reported to cause spontaneous osteoarthritis (OA) in mice. However, it is unclear whether
Smurf2 is involved in bone and cartilage homeostasis and if it is required for OA pathogene-
sis. Here we characterized age-related changes in the bone and articular cartilage of
Smurf2-deficient (MT) mice by microCT and histology, and examined whether reduced
Smurf2 expression affected the severity of OA upon surgical destabilization of the medial
meniscus (DMM). Using immature articular chondrocytes (iMAC) from MT and wild-type
(WT) mice, we also examined how Smurf2 deficiency affects chondrogenic and catabolic
gene expressions and Smurf2 and Smurf1 proteins upon TGF-β3 or IL-1β treatment in cul-
ture. We found no differences in cortical, subchondral and trabecular bone between WT
and MT in young (4 months) and old mice (16–24 months). The articular cartilage and age-
related alterations betweenWT and MT were also similar. However, 2 months following
DMM, young MT showed milder OA compared to WT (~70% vs ~30% normal or exhibiting
only mild OA cartilage phenotype). The majority of the older WT and MT mice developed
moderate/severe OA 2 months after DMM, but a higher subset of aged MT cartilage (27%
vs. 9%WT) remained largely normal. Chondrogenic gene expression (Sox9, Col2, Acan)
trended higher in MT iMACs than WT with/without TGF-β3 treatment. IL-1β treatment sup-
pressed chondrgenic gene expression, but Sox9 expression in MT remained significantly
higher than WT. Smurf2 protein in WT iMACs increased upon TGF-β3 treatment and
decreased upon IL-1β treatment in a dose-dependent manner. Smurf1 protein elevated
more in MT than WT upon TGF-β3 treatment, suggesting a potential, but very mild compen-
satory effect. Overall, our data support a role of Smurf2 in regulating OA development but
suggest that inhibiting Smurf2 alone may not be sufficient to prevent or consistently mitigate
post-traumatic OA across a broad age range.
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Introduction
Transforming growth factor-β (TGF-β) signaling consists of multiple secreted ligands such as
bone morphogenic proteins (BMPs), TGF-βs, activins, inhibins, and growth and differentiation
factors (GDFs) that regulate many cellular processes including proliferation, differentiation
and apoptosis. Its involvement in limb formation is tightly regulated in order to ensure proper
development and maintenance of bone and cartilage tissues [1]. For instance, TGF-β signaling
is essential for joint homeostasis by promoting cartilage matrix synthesis [2] and preventing
chondrocytes from undergoing terminal differentiation [3]. Aberrations in the TGF-β/BMP
signaling have thus been associated with many skeletal disorders such as osteoporosis, hetero-
topic ossifications, and osteoarthritis (OA) [4, 5]. For instance, TGF-β1 and TGF-β3 are shown
to be diminished in human and mouse OA cartilage, respectively [6, 7], and transgenic mice
that lose TGF-β signaling in cartilage recapitulate an OA-like phenotype [8–10].
One way in which TGF-β/BMP signaling is regulated is through the ubiquitin system. Ubi-
quitination is a post-translational modification that requires the step-wise effort of E1 activat-
ing enzymes, E2 conjugating enzymes and E3 ubiquitin ligases. Ubiquitinated proteins are
typically known to be targets for proteasomal degradation [11], however, non-degradative
roles have also been reported which can alter a protein’s function [12] or its localization [13].
Smad ubiquitin regulatory factor 1 and 2 (Smurf1 and Smurf2) are E3 ubiquitin ligases that
share high homology and have been shown in various cell types to regulate TGF-β/BMP signal-
ing [14]. They inhibit TGF-β signaling by promoting the degradation of R-Smads (Smads 1, 2
and 3) and TGF-β receptors [14, 15].
Based on mouse models, Smurf1 has been implicated in various signaling pathways associ-
ated with bone development and function [16]. Smurf1-deficient mice are phenotypically nor-
mal at birth, but exhibit an age-dependent increase in cortical bone mass due to sensitization of
Smurf1-deficient osteoblasts to BMP [17]. Smurf2 has been shown to be upregulated in carti-
lage explants from OA patients [18]. Using a transgenic mouse model, Wu et al. demonstrated
that overexpression of Smurf2 in articular chondrocytes results in chondrocyte hypertrophy
and accelerated cartilage degradation [18]. The potential of Smurf2 to trigger spontaneous car-
tilage degradation raises the questions as to what roles Smurf2 has during normal cartilage
development and maintenance and whether aberrant expression of Smurf2 is required for OA
development. Smurf2-deficient mice [19, 20] are born at the expected Mendelian ratio with no
obvious phenotypic abnormality, but an increased incidence of tumor formations at 15–20
months compared to wild-type (WT). To our knowledge, there has been no in-depth charac-
terization of age-dependent changes in bone and cartilage in mice with reduced Smurf2
expression.
Here, we used a Smurf2-deficient mouse model generated by gene trapping [19] to investi-
gate whether reduced Smurf2 expression affects normal skeletal development and aging and
whether it affects pathological conditions such as post-traumatic OA. Specifically, we charac-
terized femoral cortical bone, vertebral trabecular bone, knee subchondral bone and knee
articular cartilage of skeletally mature young (4 months old) and old (21 ± 1.3 months)
Smurf2-deficient (MT) mice and their WT counterparts by quantitative microcomputed
tomography (microCT) analyses and semi-quantitative histological scoring of articular carti-
lage (Fig 1A). In addition, we assessed the severity of OA symptoms of WT vs. MT mice in
both age groups in response to surgical destabilization of the medial meniscus (DMM) (Fig
1B). Lastly, we utilized primary immature chondrocytes isolated fromWT and MT mice to
assess how Smurf2 deficiency affects chondrogenic and catabolic gene expression as well as
Smurf2 and Smurf1 protein expression in 2D culture after treatment with TGF-β3 or pro-
inflammatory cytokine IL-1β.
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Materials and Methods
Breeding of Smurf2-deficient andWTMice
A previously reported Smurf2-deficient mouse model generated by gene trapping (on a C57BL/
6 background) [19] that was developed in the Zhang lab at University of Massachusetts Medical
School (Worcester, MA) was used for the study. WT and MTmice were generated by crossing
mice heterozygous for the trapped Smurf2 allele. For isolation of primary chondrocytes, homo-
zygous mice were bred to produce sufficient neonates of the same genotype. Adult mice and
neonates were euthanized by carbon dioxide asphyxiation followed by either cervical disloca-
tion (adults) or decapitation (neonates). All mice were housed in a fully accredited Animal Care
facility and the animal handling and surgical procedure were approved by the University of
Massachusetts Medical School Institutional Animal Care and Use Committee (IACUC).
Bone Marrow Stromal Cells (BMSC) Isolation
Hind legs were harvested from skeletally mature 4 months old WT and MTmice. Excess mus-
cles were trimmed off and one end of the tibiae and femur was cut. Adopting a literature
method [21], bone marrow (BM) plugs were isolated by inserting a 25-gauge syringe needle
into the uncut end of the long bones and flushing with serum-free α-MEM. The BM plugs were
mechanically disrupted using a pipettor and filtered through a 70-μmmesh to remove excess
debris. Red blood cells were lysed by mixing with an equal part of sterile water for<10 sec fol-
lowed by a 1:5 dilution in 1×PBS. Cells were pelleted at 400g for 10 min and resuspended in
complete culture media (α-MEMwith 20% hyclone FBS, 1% L-glutamine, and 1% pen/strep).
The total cell suspension was plated on two p100 plates and media were changed twice a week.
Immature Murine Articular Chondrocyte (iMAC) Isolation
Following a literature protocol [22], iMACs were isolated from 5 to 7 day-old neonates. Carti-
lage from the knee and ankle joints were harvested, pooled together and subjected to a 60-min
Fig 1. Summary of experimental design for skeletal characterizations.
doi:10.1371/journal.pone.0148088.g001
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digestion in type II collagenase (Worthington) solution (3mg/mL in high glucose DMEM with
1% pen/strep) at 37°C under agitation. The cartilage pieces were then transferred to a diluted
collagenase solution (0.5mg/mL) and incubated for 5–6 hours at 37°C under moderate agita-
tion. The solution with residual fragments were mixed to yield a single cell suspension and fil-
tered through a 70-μm nylon mesh. The chondrocytes were pelleted at 400g for 10 min, washed
in PBS and then resuspended in DMEM/F12 with 10% FBS. The cells were plated at a density
of 2.5 x 104 cells/cm2 and cultured for 4–6 days before subsequent in vitro treatments and anal-
yses. The chondrogenic nature of these cells was confirmed by positive Alcian Blue staining for
cartilage ECM and the expression of chondrogenic gene which decreased with multiple
passaging.
Whole Tissue Dissection
The hind legs from 4 months old WT and MT were harvested and each leg was dissected into
1) muscles surrounding the tibia and femur, 2) knee joint including the patella, ligaments and
the tibial and femoral articular ends, and 3) mid-shaft tibia and femur with intact bone mar-
row. The spleen was harvested as a control where Smurf2 is known to be highly expressed in
the WT. All specimens were immediately frozen in liquid nitrogen, powderized using a mortar
and pestle, and stored at -80°C until time for protein or RNA isolation.
Western blot for BMSCs, iMACs, and musculoskeletal tissues
Total cell lysates from Passage 0 BMSCs and iMACs were extracted using RIPA buffer (50mM
Tris pH 7.5, 150mMNaCl, 1% Triton X, 1mM EDTA, 0.1% SDS, 0.5% Na-deoxycholate) sup-
plemented with a protease inhibitor cocktail (Roche). For protein isolation from whole bone,
joint and skeletal muscle, powderized specimens were resuspended in RIPA. Protein lysates
(25–60μg) were separated by SDS-PAGE mini-protean gels (Bio-Rad) and transferred to nitro-
cellulose membranes. Membranes were probed using primary antibodies against Smurf2
(Abcam, 1:1000), Smurf1 (Abcam, 1:2000), Col2 (Millipore, 1:2000), Sox9 (Millipore, 1:1000),
GAPDH (Sigma, 1:5000), tubulin (Sigma, 1:5000) and goat secondary antibodies against rabbit
(1:5000) and mouse (1:10,000) IgG and then visualized using a chemiluminescent substrate
(Pierce).
RT-PCR for Smurf2 mRNA levels in whole bone and cartilage tissues
Powderized tissues were resuspended in TRIzol reagent (Life Technologies) and vortexed at
room temperature for 15–20 min. Insoluble components were removed by centrifugation
(12,000g, 10 min). RNA was purified using Direct-zol RNAMiniPrep (Zymo Research) accord-
ing to manufacturer’s instructions and RNA concentration was determined using a Nanodrop
2000 spectrophotometer (Thermo Scientific). Total RNA (1 μg) was reverse-transcribed using
SuperScript III First-Strand Synthesis Kit (Life Technologies) according to manufacturer’s
instructions. PCR reactions were conducted on a GeneAmp PCR system 2700 (Applied Biosys-
tems) under the following conditions: 94°C for 3 min, followed by 35 cycles at 94°C for 20 sec,
58°C for 30 sec, 72°C for 1 min, and a final extension at 72°C for 10 min. PCR products were
subjected to electrophoresis on a 1% agarose gel and visualized by ethidium bromide staining.
RT-PCR primer sequences: Smurf2 (Fwd: 5’-AACCGTGCTCGTCTCTCTTC-3’, Rev: 5’-
ATGAAGTCATTCCCCAGCAC-3’); GAPDH (Fwd: 5’-AGGTCGGTGTGAACGGATTTG-3’,
Rev: 5’-TGTAGACCATGTAGTTGAGGTCA-3’.)
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Preparation of skeletal tissues for microCT and histology
For analysis of knee joints by microCT and histology, hind legs were harvested from skeletally
mature young (4 months old) and old (21 ± 1.3 month old) male mice, tied to a toothpick in a
fully extended position, and fixed in 10% neutral buffered formalin for 2–3 days at 4°C before
being scanned and subsequently decalcified for histology. For analysis of femoral cortical bone
and vertebral trabecular bone, hind legs from 4 and 18 month old mice and lumbar vertebrae
from 16 month old male and female mice were harvested and fixed in 10% neutral buffered for-
malin for 2–3 days at 4°C before being scanned by microCT and subsequently decalcified for
histology.
Quantitative MicroCT analyses
All skeletal tissues were scanned on a Scanco microCT 40 scanner (Scanco Medical, Brüttisel-
len, Switzerland) at a 10-μm voxel resolution. Cortical bone analysis was performed by evaluat-
ing 50 slices (volume of interest/VOI) from the midshaft (10 micron spacing, flanking the
midpoint between growth plates of the femur) for bone volume, cortical thickness, and bone
mineral density. Vertebral bone analysis was performed on either the L4 or L5 vertebrae and
the region of interest (ROI) was defined by the entire trabeculae within the body of the vertebra
excluding the cortical bone (S1A Fig). The bone volume/tissue volume (BV/TV), trabecular
thickness, trabecular spaces, and bone mineral density were determined using Scanco’s trabec-
ular bone evaluation that is based on distance transformations (Direct-No model method). For
subchondral bone analysis, the medial and lateral condyles of the proximal tibia epiphysis were
analyzed separately. The ROI was defined by the bone between the calcified cartilage and the
growth plate (S1B Fig). The bone volume/tissue volume (BV/TV), trabecular thickness, trabec-
ular spaces, and bone mineral density were calculated using the same trabecular bone evalua-
tion method as the vertebrae. For subchondral bone analysis after DMM surgery, only the
medial condyle of the tibia was evaluated and osteophytes were excluded from the ROI.
Knee Histology and Semi-Quantitative Scoring of Articular Cartilage
Formalin-fixed hind legs were decalcified for 14 days in 18% EDTA and frontally embedded in
paraffin blocks. Blocks were cut using a Reichert-Jung 2030 microtome to produce 5μm thick
sections. Sections were deparaffinized then stained with Weigert’s iron hematoxylin/fast green/
safranin-O (Sigma). To systematically compare knee articular cartilages, a minimum of five
equally spaced sections spanning the knee joint were analyzed using a modified literature semi-
quantitative scoring criteria [23]. Articular cartilage with loss of staining or superficial struc-
tural damage was referred to as mild OA (scores of 0.5 and 1), while fibrillations and erosions
with increasing depth and width below the superficial layer and extending past tidemark were
referred to as moderate (scores of 2 and 3) or severe OA (score of 4). Sections with majority of
the subchondral bone exposed or only a small portion of articular cartilage intact were catego-
rized as very severe OA (scores of 5 and 6). The medial femoral and tibial articular cartilages of
each knee section were blindly scored by 7 trained examiners. The scores from each examiner
were averaged and the average scores for the femoral and tibial cartilage were plotted separately
on the same graph for semi-quantitative comparisons.
Surgical Induction of OA by Destabilization of Medial Meniscus (DMM)
DMM, a well-established surgical model for inducing OA [24], was performed on 2 months
old and 19 ± 1.3 month old male mice. Briefly, the mice were anesthetized using 2% isoflurane
in oxygen, and the surgical site was sterilized before a medial parapatellar incision was made to
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expose the joint cavity. The meniscotibial ligament was identified and transected under a ste-
reomicroscope. Joint capsule and overlying skin were sutured in layers using 7–0 PGA sutures.
Buprenorphine (0.05mg/kg, 3 times a day) and cefazolin (20mg/kg, twice a day) were injected
subcutaneously immediately post-operation (post-op) and for 2 more days thereafter. Mice
were allowed to move freely in cages immediately after the operation. At 2 months post-DMM,
the mice were euthanized and their hind legs were harvested and prepared for microCT and
histology analyses as described above.
Quantitative RT-PCR (qPCR) of Primary Chondrocytes
iMACs were isolated fromWT and MT mice as described above. Cells were seeded at 2.5 x 104
cells/cm2 and cultured in expansion media (5% FBS in DMEM/F12) for 4 days on tissue culture
polystyrene (TCPS). Cells were then treated with 10 ng/mL of TGF-β3 (R&D Systems) or 5 ng/
mL of IL-1β (R&D Systems) for 24 hours. RNA was isolated, purified and reverse-transcribed
as described above. qPCR samples were prepared using Power SYBR Green Master Mix
(Applied Biosystems) and analyzed using 7500 Real-Time PCR System (Applied Biosystems).
Gene expressions of Sox9, Col2, Acan, Col1, MMP-3, MMP-9, MMP-13, and ADAMTS5 were
normalized to β-actin levels. Data were plotted as fold change relative to those of untreated
WT. Primer sequences are summarized in Table 1.
Statistical Analysis
Statistical analyses were performed using Prism (Graphpad Software, Version 6.0). MicroCT
data were presented as the mean ± standard deviation and the statistical analyses were per-
formed using 2-way ANOVA followed by Tukey’s post hoc test. Knee histological scores were
plotted as a dot plot with the median and interquartile range, and the statistical analyses were
performed with either Kruskal-Wallis with Dunn’s multiple comparison test (for age and geno-
type-dependent changes) or the Mann-Whitney rank-sum test (response to DMM surgery).
Distribution of the histological scores from post-DMMWT and MT knees were compared
using Kolmogorov-Smirnov test. qPCR results are presented as a mean ± standard deviation of
three separate chondrocyte isolation experiments for each genotype and the statistical analysis
was performed using unpaired t-test for each treated and untreated condition. Quantifications
of WB bands were normalized to WT expansion media control and averaged among three rep-
licates. A value of p< 0.05 was considered statistically significant.
Table 1. Sequences of primers used for quantitative RT-PCR.
Gene NCBI Ref Seq Forward Primer Sequence 5’-3’ Reverse Primer Sequence 5’-3’ Primer Size (bp)
β-Actin NM_007393.3 CGAGCGGTTCCGATGC TGGATGCCACAGGATTCCAT 69
SOX9 NM_011448.4 AGGAAGCTGGCAGACCAGTA CGTTCTTCACCGACTTCCTC 193
COL2 NM_031163.3 GATCACCTCTGGGTCCTTGTT TCCTCTGCGATGACATTATCT 222
ACN NM_007424.2 AGTGGATCGGTCTGAATGACAGG AGAAGTTGTCAGGCTGGTTTGGA 105
COL1 NM_007742.3 AACGAGATCGAGCTCAGAGG CACGAAGCAGGCAGGGCCAA 213
MMP-3 NM_010809 AGTCTACAAGTCCTCCACAG TTGGTGATGTCTCAGGTTCC 152
MMP-9 NM_013599.3 TAGCTACCTCGAGGGCTTCC GTGGGACACATAGTGGGAGG` 147
MMP-13 NM_008607.2 AGACCTTGTGTTTGCAGAGCACTAC CTTCAGGATTCCCGCAAGAGT 70
ADAMTS5 NM_011782.2 CGAAGAGCACTACGATGCAG TGGAGGCCATCATCTTCAAT 144
doi:10.1371/journal.pone.0148088.t001
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Results
Characterization of Smurf2 Expression in skeletal tissues
To study the role of Smurf2 in skeletal tissues, we began by examining the levels of Smurf2
expression in theses tissues. The level of Smurf2 protein in knee joints, cortical bones/bone
marrow, and skeletal muscles of C57BL/6 WTmice was undetectable compared to levels in the
spleen by western blot (Fig 2A). Using RT-PCR, we confirmed that the total mRNA levels of
Smurf2 extracted from these skeletal tissues were much lower than in the spleen, but all MT tis-
sue examined showed reduced Smurf2 mRNA expression compared to WT as expected (Fig
2B). We also examined Smurf2 expression in bone marrow stromal cells (BMSC) and imma-
ture murine articular chondrocytes (iMAC) isolated fromMT andWTmice, and found that
Smurf2 protein levels are significantly reduced in both MT primary cells (Fig 2C).
Fig 2. Smurf2 protein and gene expressions in WT (+/+) and Smurf2-deficient MT (T/T) skeletal tissues
and primary cells. (A) Protein expression of Smurf2 in various skeletal tissues from healthy 4 month old
male WT and MTmice. Spleen, where Smurf2 is highly expressed, is included as a positive control. (B)
Smurf2 mRNA expression in various skeletal tissues compared to spleen in 4 month old male WT and MT
mice. (C) Protein expression of Smurf2 in bone marrow stromal cells (BMSC, passage 0) isolated from 4
month old WT and Smurf2-deficient MT mice and immature articular chondrocytes (iMAC, passage 0)
isolated fromWT and MT neonates.
doi:10.1371/journal.pone.0148088.g002
Characterization of Smurf2-Deficient Mice and Chondrocytes
PLOS ONE | DOI:10.1371/journal.pone.0148088 January 27, 2016 7 / 18
Smurf2-deficient mice exhibit normal age-dependent cortical and
trabecular bone phenotypes
Using microCT, we examined changes in mid-shaft femoral cortical bone between WT and
MTmice at 4 months and 18 months of age. Although a slight drop in bone mineral density
(BMD) was observed with advanced age, these changes were not statistically significant. No sig-
nificant difference between WT and MTmice at a given age was detected (Fig 3A).
Due to its high surface area to bone matrix volume ratio, trabecular bone undergoes more
rapid remodeling and is associated with more prominent bone loss with age than in cortical
bone [25]. We therefore assessed the vertebral trabecular bone in 16 month old mice using
microCT to reveal potential remodeling abnormality between genotypes. To account for the
effect of estrogen deficiency on bone remodeling, these analyses were performed in a gender-
specific manner (Fig 3B and 3C). Regardless of genotype, the vertebral trabecular bone of old
female mice exhibited lower BV/TV and higher trabecular thickness and trabecular spaces
than their male counterparts. These gender-specific differences were not statistically different
between WT and MT mice.
Fig 3. Age- and gender-specific cortical bone and trabecular bone analyses of WT and Smurf2-deficient MTmice. (A) Mid-shaft cortical bone analysis
of male WT and MT femurs from 4 month (WT: n = 6; MT: n = 7) and 18 month old (WT and MT: n = 7) mice. (B) Gender-specific trabecular bone analysis of
lumbar vertebrae from 16 month old WT and MTmice (Male: n = 7; Female: n = 5). (C) Representative 3D reconstruction of contoured vertebral trabecular
bone. Scale bar = 500 μm.
doi:10.1371/journal.pone.0148088.g003
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Smurf2-deficient mice exhibit normal knee joint phenotype
Qualitative comparison of histological sections of WT and MT knee joints did not reveal any
gross developmental or age-related abnormalities within the growth plates, menisci, or syno-
vium (S2 Fig). In order to characterize the structural changes in knee articular cartilage that
would reflect spontaneous OA development with age, we adopted from literature a semi-quan-
titative knee histological scoring system [23] and categorized each score to an overall OA sever-
ity (Fig 4A). Since lateral tibial articular cartilage tends to be thinner with less distinct zonal
architecture [26], we focused our analyses on the medial side. Using this scoring system, we
detected age-dependent changes in the articular cartilage from normal to mild OA in the
medial tibial and femoral condyles in both the WT (p = 0.0011) and MT (p< 0.0001) mice, but
Fig 4. Age-specific knee joint phenotypes of maleWT (+/+) and Smurf2-deficient MT (T/T) mice. (A) Normal and osteoarthritic joint articular cartilage
histology scoring criteria modified over literature method[27] along with representative safranin O-stained cartilage sections. Yellow line indicates tidemark;
Black arrows denote loss of staining, fibrillations, or erosions. (B) Combined histology scores of femoral and tibial articular cartilage of 4 month old WT
(n = 13), 4 month old MT (n = 13), 21 month WT (n = 11), and 21 month old MT (n = 11). (C) Representative microCT images of bone mineral density color
mappings of mid-frontal knee sections from young and old WT and Smurf2 MT mouse knees. Red indicates higher BMDwhile green indicates lower BMD. D)
Quantitative comparisons of the lateral and medial subchondral bone analyses between 4 month (WT: n = 9; MT: n = 11) and 21 month (WT: n = 10; MT:
n = 8) WT and MTmice. *p<0.05.
doi:10.1371/journal.pone.0148088.g004
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no statistically significant difference was detected between them at a given age (Fig 4B). The
main differences observed between the two age groups ranged from general loss of proteogly-
can staining to mild superficial fibrillations as reflected by the median scores of 0.64 (0.35–
0.72) and 0.57 (0.41–0.67) in the 21 month old WT and MT groups, and 0.26 (0.14–0.36) and
0.14 (0.06–0.26) in the young 4 month old WT and MT groups, respectively.
We then investigated whether age-dependent changes in the tibial subchondral bone were
different between WT and MT. Since previous work reported differences in the medial and lat-
eral compartments of the subchondral bone [27], we analyzed microCT data in these two com-
partments separately. Compared to the lateral side, the medial subchondral bone compartment
had a higher BV/TV, trabecular thickness and BMD across both age groups and genotypes (Fig
4C and 4D). The age-dependent loss of trabecular bone within the medial compartment was
also apparent as supported by the increase in trabecular spacing, from 0.154±0.011 (WT) and
0.175±0.027 (MT) in the young group to 0.193±0.026 (WT) and 0.229±0.036 (MT) in the old
group, respectively. However, no statistically significant differences were detected between WT
and MT mice at a given age.
Young Smurf2-deficient mice develop milder OA in knee articular
cartilage compared to WTmice after DMM surgery
DMM is a well-established surgical-induced model of OA in mice that mimics the slow pro-
gression of human OA following traumatic knee injury [24]. To determine whether Smurf2
deficiency affects the pathological development and progression of OA or alter the repair
mechanisms in response to knee injury, we performed DMM surgery on 2 month old male WT
and MTmice and evaluated their knee articular cartilage by histological scoring after 2 months.
Histological sections from the medial side of the DMM-operated knees revealed cartilage ero-
sions extending below the superficial layer and past the tidemark in the WT mice while mainly
loss of proteoglycan staining and superficial fibrillations were observed in the MT DMM knees
(Fig 5A). This difference resulted in a post-DMMmedian histological score of 1.85 (0.91–3.80)
for WT and 1.00 (0.59–1.78) for MT, both of which were significantly higher than the respec-
tive un-operated contralateral controls (p< 0.0001) and significantly different from each other
(p< 0.01) (Fig 5B). We also observed a profound difference in the distribution of the post-
DMM histology scores between WT and MT, which was verified using the Kolmogorov-Smir-
nov test (p = 0.043). The difference in the distribution of cartilage scores between WT and MT
knees in response to DMM is best reflected by categorizing the OA severity of each scored spec-
imen (Fig 5C). Specifically, while all WT mice developed knee OA 2 months after DMM, with
69.2% of the articular cartilage exhibiting moderate (42.3%) to severe/very severe (26.9%) OA
phenotypes, 69.2% of the articular cartilage fromMT mice knees developed either mild OA
(50.0%) or remained normal (19.2%). Only 30.8% of the MT mice exhibited moderate OA car-
tilage phenotype at 2 months after DMM and none exhibited severe or very severe OA
symptoms.
Since sclerosis of the subchondral bone has been detected in mice after DMM surgery, we
evaluated whether Smurf2-deficiency affected the degree of sclerosis. Representative images of
WT and MT DMM knees revealed increased bone mineral density localized in the medial fem-
oral condyle and the tibial plateau at 2 months after DMM (S3A Fig). Quantitative analysis of
the medial subchondral compartment of the tibia (S3B Fig) showed an increasing trend in tra-
becular thickness in both WT and MT. The concurrent loss of trabecular space is more appar-
ent in the MT mice. The changes in BMD detected before and after DMM surgery in either
genotype was not statistically significant, likely due to the large standard deviation among the
WT subchondral bone in response to DMM.
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Aging increases severity of OA in both WT and MT knees but the subset
of mice exhibiting normal or mild OA is still greater in MT
Since age is a risk factor for OA development, we performed DMM surgery on older (19 ± 1.3
month) Smurf2-deficient mice to examine whether the attenuated OA cartilage phenotype
observed at 4 months may be sustained with age. Histological scores of the older knees 2
months post-DMM revealed that aging increased the overall severity of OA symptoms for both
WT (p< 0.05) and MT mice (p< 0.001) (Fig 5D and 5E). The median post-DMM histological
scores for the older mice were 3.02 (2.00–4.00) for WT and 2.56 (1.32–4.32) for MT, but the
reduction in OA severity in MT was not statistically significant (p = 0.460) based on mean
ranks comparison. Unlike the 4 month old mice, the distribution of histological scores were
also similar between the old WT and MT mice as verified by the Kolmogorov-Smirnov test
(p = 0.621). It is interesting to note, however, the subset of mice exhibiting normal or mild OA
articular cartilage symptoms post-DMM at such an advanced age was still greater in the MT
mice (27.3%) than in the WT mice (9.1%).
Smurf2-deficient chondrocytes display elevated chondrogenic gene
expression in 2D culture compared to WT
To examine how Smurf2 deficiency might affect chondrocyte function in a chondrogenic or
pathological environment in 2D culture, we isolated iMACs fromWT and MT mice and
Fig 5. Differential severity of knee joint articular cartilage erosions in young (4 month) and old (21 ± 1.3 month) maleWT and Smurf2-deficient MT
mice after DMM surgery. (A) Representative images of safranin O-stained articular cartilage sections from the medial compartment of WT and MT knees 2
months post-DMM surgery. (B) Semi-quantitative histology scores of the femoral and tibial articular cartilage of DMM knees vs un-operated controls (n = 13
for 4 month; n = 11 for 21 ± 1.3 month). The average femoral and tibial articular cartilage scores for each joint were plotted separately on the same graph.
Groups with the same symbol are not statistically significant (p > 0.05) based on mean ranks. (C) Distribution of DMM knee scores for WT and MT based on
OA severity.
doi:10.1371/journal.pone.0148088.g005
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compared the gene expression of key anabolic and catabolic genes in the presence of chondro-
genic factor, TGF-β3 or proinflammatory cytokine, IL-1β. MT chondrocytes showed trend of
higher levels of chondrogenic gene expression (Sox9, Col2, and Acan) thanWT with and with-
out addition of TGF-β3 (Fig 6). In the presence of pro-inflammatory cytokine IL-1β at 5 ng/
mL, an overall decrease in the expression of chondrogenic genes Sox9, Col2, and Acan and an
increase in the expression of catabolic genes MMP-3, MMP-9, MMP-13 and ADAMTS5 were
observed in bothWT and MT. It is worth noting that the trend of higher levels of chondrogenic
genes in MT than WT persisted even under the inflammatory conditions, with the higher Sox9
expression in MT being statistically significant. Although there was no consistent trend in the
expression of catabolic genes between WT and MT iMACs, there was a statistically significant
difference in MMP13 and ADAMTS5 expression between WT and MT upon IL-1β treatment.
The level of Col1, a marker for chondrocyte dedifferentiation, was similar across all conditions
between genotypes. We were unable to detect Col10 expression in iMACs from either genotype
after 40 cycles.
TGF-β3 and IL-1βmodulates Smurf1 and Smurf2 expression in iMACs
in vitro
To determine whether Smurf2 and Smurf1 protein levels are perturbed in chondrogenic or
pathological conditions, we detected their expressions in WT iMACs after TGF-β3 or IL-1β
treatment by western blot. Treatment of WT iMACs with TGF-β3 caused a dose-dependent
increase in Smurf2 while treatment with IL-1β resulted in a dose-dependent decrease (Fig 7A).
Even though the treatment of iMACs with TGF-β3 widened the level of Smurf2 between WT
and MT, the difference in protein expression of Col2 and Sox9 between WT and MT were not
as apparent (Fig 7B). Smurf1, which shares high homology with Smurf2, appeared slightly
Fig 6. Quantitative gene expression analyses of key anabolic and catabolic markers in WT andMT iMACs.Cells were cultured as a monolayer on 2D
tissue culture polystyrene for 4 days and treated with either 10 ng/mL of TGF-β3 or 5 ng/mL of IL-1β for 24 hours. Data are reported as the mean ± standard
deviation of three separate chondrocyte isolations for each genotype. EM = Expansion Media, *p < 0.05 (p values approaching significance are noted on the
graph).
doi:10.1371/journal.pone.0148088.g006
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elevated in MT iMACs compared to WT after TGF-β3 treatment, but quantification of the
intensities of these bands did not reveal statistical significance (S4 Fig).
Discussion
In this study, we characterized bone and joint phenotypes of Smurf2-deficient mice as a func-
tion of age on the basis that Smurf1 and Smurf2 have been implicated in regulating bone and
cartilage function, respectively. Using microCT and histological analyses, we compared age-
dependent changes in femoral cortical bone, vertebral trabecular bone (gender-specific), tibial
subchondral bone and knee articular cartilage between WT and Smurf2-deficient MT mice.
We found that the reduction of Smurf2 expression did not impact the normal development
and maintenance of bone and cartilage throughout adulthood and the observed bone and carti-
lage changes as a function of age are consistent with previous reports on aged WT C57BL/6
mice [26, 28–30].
Fig 7. Smurfs protein expression changes upon 24-h treatment of TGF-β3 and IL-1β. A) WT
chondrocytes show dose-dependent increase of Smurf2 protein with 24-h TGF-β3 treatment and dose-
dependent decrease with 24-h IL-1β treatment. B) No compensatory increase of Smurf1 protein levels was
detected betweenWT (+/+) and Smurf2-deficient MT chondrocytes (T/T) with and without treatment of TGF-
β3 (10 ng/mL) or IL-1β (0.1 ng/mL). Type 2 collagen levels were also similar betweenWT and MT
chondrocytes across all conditions.
doi:10.1371/journal.pone.0148088.g007
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Since the overexpression of Smurf2 in chondrocytes was reported to trigger spontaneous
OA [18], we subjected skeletally mature 2 month old Smurf2-deficient mice to DMM surgery
and examined whether their development of OA is mitigated compared to WT. We observed
that at 2 months post-DMM, MT mice were less susceptible to pathological development of
OA compared to WT. Based on our OA severity categorization criterion, the majority of articu-
lar cartilage fromWT DMM knees developed moderate to severe OA (69.2%; characterized by
significant cartilage fibrillations and erosions extended beyond the tidemark and into subchon-
dral bone) while the majority of articular cartilage fromMT DMM knees were normal or devel-
oped only mild OA (69.2%). More remarkably, not only did none of the articular cartilage
fromMT DMM knees develop severe OA, but a subset of them remained normal (19.2%). In
contrast, none of the articular cartilage fromWT knees were normal 2 months after DMM and
a subset of them developed severe to very severe OA by 2 months (26.9%). The presence of sub-
chondral bone sclerosis and osteophyte formation has long been associated with human OA
knees. However, it remains controversial whether subchondral bone changes are an etiology of
OA or whether they reflect a bone remodeling process that reacts to the deteriorating overlay-
ing cartilage [31]. From our study, we did not detect any significant changes in subchondral
bone sclerosis (S2 Fig) or osteophyte formation between genotypes by 2 months post-DMM,
suggesting that the subchondral bone remodeling process induced by DMM is not entirely
dependent on Smurf2 expression or the integrity of the overlaying cartilage.
Given that the impact of Smurf2 on cartilage progressed with age and that Smurf2 defi-
ciency have been implicated to inhibit cellular senescence [19], we questioned whether the pro-
tective effect of Smuf2 deficiency against OA development after DMM surgery may sustain
with age. Histological scores of the joint articular cartilage showed that aging caused both WT
and MT mice to develop more severe OA after DMM surgery, with an increase of the median
score for the 21 month old WT (3.02 vs. 1.85) and MT (2.56 vs. 1.00) when compared to 4
month old counterparts. Nevertheless, we found that the subset of joint cartilage that remained
normal or exhibited only mild OA phenotype post-DMM is still greater among old MT than
WT, suggesting that some degree of protective effect may still persist at this age. Because the
majority of the specimens do develop moderate to severe OA, a larger sample size is necessary
to demonstrate the significance of this subset between old WT and MT. Altered biomechanics
due to weight changes and impaired bone and cartilage repair and homeostasis due to aging
can all potentially mask the protective effect of Smurf2 deficiency on OA development. Overall,
the effectiveness of Smurf2 inhibition to delay, alleviate or prevent OA symptoms in the multi-
tissue compartments of the joint, particularly at advanced age, requires further investigation.
Taking advantage of this Smurf2-deficiency mouse model, we isolated immature articular
chondrocytes from newborn mice and asked how Smurf2 deficiency affects the expression of
common chondrogenic and catabolic genes upon culture treatment with TGF-β3 or IL-1β.
Pro-inflammatory cytokine IL-1β is known to shift the balance of chondrocytes from matrix
synthesis towards degradation and has been used to emulate an inflammatory OA environ-
ment in vitro [32, 33]. We found that MT chondrocytes trended toward a higher transcription
level of chondrogenic genes including Sox9, Col2, and Acan compared to WT with and without
TGF-β3 treatment. As expected, IL-1β treatment of the chondrocytes globally suppressed
chondrogenic genes and upregulated the catabolic genes that we examined. The general trend
of higher chondrogenic gene expression in the MT thanWT was maintained even under proin-
flammatory conditions, with the difference in Sox9 being statistically significant and that of
Col2 approaching significance. The differences observed between WT and MT iMACs at the
mRNA level, however, did not translate directly to the protein level. We found no difference in
Col2 protein expression and Sox9 protein expression was only slightly higher in the MT
iMACs treated with TGF-β3 compared to WT. Interestingly, both Col2 and Sox9 expression
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seems to decrease after 24 hour treatment with TGF-β3 compared to untreated cells. We con-
firmed that this increase in chondrogenic gene expression was not due to differences in the
degree of dedifferentiation between WT and MT in vitro by demonstrating that Col1 expres-
sion was similar across all experimental conditions. On the contrary, there was no consistent
trend in the expression of catabolic genes examined (MMP-3, -9, -13 and ADAMTS5) between
WT and MT. Compared to WT iMACs, MT iMACs had statistically significant lower expres-
sion of MMP3 upon TGF-β3 treatment, but higher expression of MMP-13 and ADAMTS5
after IL-1β treatment. In the absence of TGF-β3 or IL-1β, no significant differences in any cata-
bolic genes were detected. Incidentally, we found that both TGF-β3 and IL-1βmodulated
Smurf2 levels in WT iMACs in a dose-dependent manner. TGF-β3 also increased Smurf1 levels
and the increase was higher in MT chondrocytes than in WT, suggesting a potential but weak
compensatory mechanism by Smurf1 in Smurf2-deficient iMACs. Whether TGF-β3-induced
increase of Smurf1 and Smurf2 affects the phosphorylation of intracellular R-Smads or the sta-
bility of TGF-β receptors or other downstream effector proteins remain to be determined.
Despite previous reports demonstrating the effect of Smurf to modulate the TGF-β/BMP
signaling pathway [34, 35] and the importance of this pathway in bone and cartilage develop-
ment [36–38], the lack of an obvious skeletal phenotype in MT mice during normal develop-
ment and aging as elucidated by this study has a few implications. It suggests that a high level
of Smurf2 expression may not be required for bone and cartilage development and that the low
levels of Smurf2 present in the MT mice may be sufficient to maintain normal physiological
activities. In addition, Smurf1 may have redundant functions that can compensate for the
reduced Smurf2 levels during normal development and aging, and account for the moderate
and weak protection against OA development observed in young and old Smurf2-deficient
mice, respectively.
There are a few limitations of our study. First, it is unclear whether reduced Smurf2 expres-
sion functions to delay the onset of OA and/or hinders its progression. We have not identified
the exact stress signals produced by DMM that can trigger Smurf2 activity or stimulate its
expression beyond physiological levels, which could help establish a molecular basis of how
Smurf2 drives OA pathogenesis. Second, besides articular cartilage and subchondral bone,
other joint tissue compartments involved in OA pathogenesis such as synovium, muscles and
bone marrow were not examined in this study. Third, the use of immature articular chondro-
cytes, driven by its ease of isolation, to compare the chondrogenic potential of WT and MT
cells may not be ideal. Not only is the population of iMACs heterogenous with varying degrees
of differentiation, but their response to exogenous growth factors and cytokines may be differ-
ent from the chondrocytes residing in matured articular cartilage. Tissue-specific Smurf2-defi-
cient cells (e.g. obtained via conditional knockouts) may be more accurate at correlating the
potential cellular contributors within the multi-tissue joint compartment to the protective OA
phenotype observed in MT mice after DMM. Lastly, to unequivocally establish the redundant
function of Smurf1 and Smurf2 in chondrocytes, validation by simultaneous knock down
experiments would be desired.
In summary, we show that while loss of Smurf2 in mice has no physiological impact on
bone and cartilage development and aging, its ability to attenuate OA symptoms after DMM
surgery in 4 month old mice indicate a potential role in regulating the pathological develop-
ment of OA. Whether Smurf2 inhibition alone is sufficient to be a therapeutic target for OA
remains unclear since the protective effect of Smurf2 in older mice is markedly reduced com-
pared to the younger age group. The enhanced chondrogenic gene expressions in MT iMACs
compared to WT suggest a potential for enhanced cartilage matrix deposition, but the optimal
condition to facilitate its translation into meaningful enhancements in cartilage regeneration
remain to be identified.
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Supporting Information
S1 Fig. ROI Definitions of microCT Analysis. (A) ROI within L4/L5 vertebrae indicated by
the green contour; (B) ROI within the lateral and medial compartments of tibial subchondral
bone indicated by green and red contours, respectively. Contour of medial compartment
excluded osteophyte projection and the overlying calcified cartilage.
(TIF)
S2 Fig. Representative safranin O-stained knee joint histological sections of young and old
WT versus Smurf2-deficient MTmice.
(TIF)
S3 Fig. Knee joint subchondral bone analyses in 4 months old male WT and Smurf2-defi-
cient MT mice upon surgical induction of OA by DMM. A) Representative microCT bone
mineral density (BMD) color mapping of medial compartment of 4 month old male mice knee
2 months post DMM.White arrows = areas with increased bone mineral content; L = lateral;
M = medial; red indicates higher BMD while green indicates lower BMD. B) Quantification of
subchondral bone change in medial compartment of tibial plateau after DMM reflecting trends
of increased BV/V, trabecular thickness and decreased trabecular spaces. WT: n = 9; MT:
n = 11.
(TIF)
S4 Fig. Western blot quantification of Smurf2 and Smurf1 proteins in WT and MT iMACs.
Protein bands for Smurf2 and Smurf1 bands were quantified and normalized to WT iMAC in
expansion media (EM). Quantification was based on the average of three separate experiments
with different WT and MT pairs. n.d. = not detected.
(TIFF)
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